Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01827176
Other study ID # 094/2556(EC4)
Secondary ID
Status Completed
Phase N/A
First received March 25, 2013
Last updated March 21, 2017
Start date March 2013
Est. completion date September 2014

Study information

Verified date March 2017
Source Mahidol University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine the clinical characteristic of recurrent acute rhinosinusitis in children.


Recruitment information / eligibility

Status Completed
Enrollment 94
Est. completion date September 2014
Est. primary completion date April 2014
Accepts healthy volunteers No
Gender All
Age group N/A to 15 Years
Eligibility Inclusion Criteria:

- Children the age less than 15 years with recurrent acute rhinosinusitis who are attending the pediatric allergy clinic during Jan 2010 - Dec 2012.

Exclusion Criteria:

- Children who had lost medical record.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Recurrent Acute Rhinosinusitis
Clinical Characteristic of Recurrent Acute Rhinosinusitis

Locations

Country Name City State
Thailand Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Mahidol University

Country where clinical trial is conducted

Thailand, 

References & Publications (1)

Veskitkul J, Vichyanond P, Pacharn P, Visitsunthorn N, Jirapongsananuruk O. Clinical characteristics of recurrent acute rhinosinusitis in children. Asian Pac J Allergy Immunol. 2015 Dec;33(4):276-80. doi: 10.12932/AP0591.33.4.2015. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Number of sinusitis after received treatment 12 months
Other Immunological profile immunoglobulin level and immunoglobulin G subclass level 12 months
Other Number of participants with allergic rhinitis 12 months
Other Number of participants with immunodeficiency 12 months
Other Number of participants with adenotonsillar hypertrophy 12 months
Primary Presenting symptoms of recurrent acute rhinosinusitis 12 months
Secondary Age of onset 12 months